Oxford BioDynamics (LON:OBD) Hits New 52-Week Low at $16.00

Shares of Oxford BioDynamics Plc (LON:OBDGet Rating) reached a new 52-week low on Friday . The company traded as low as GBX 16 ($0.19) and last traded at GBX 16.69 ($0.20), with a volume of 133766 shares traded. The stock had previously closed at GBX 17.50 ($0.21).

Separately, Shore Capital reiterated a “house stock” rating on shares of Oxford BioDynamics in a research note on Friday, February 25th.

The company has a quick ratio of 2.64, a current ratio of 2.91 and a debt-to-equity ratio of 98.42. The business has a 50 day simple moving average of GBX 19.32 and a two-hundred day simple moving average of GBX 25.81. The firm has a market cap of £16.75 million and a PE ratio of -2.33.

In related news, insider Paul Stockdale acquired 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 6th. The shares were bought at an average price of GBX 18 ($0.22) per share, with a total value of £5,400 ($6,554.19). Also, insider Matthew Wakefield acquired 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 20th. The shares were bought at an average cost of GBX 17 ($0.21) per share, for a total transaction of £4,250 ($5,158.39).

Oxford BioDynamics Company Profile (LON:OBD)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.